Ovid Therapeutics Inc (OVID)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -37,017 | -25,765 | -13,356 | -54,169 | -42,664 |
| Depreciation Amortization | 428 | 282 | 145 | 1,382 | 942 |
| Accounts payable and accrued liabilities | -736 | 1,810 | -121 | -5,174 | -6,094 |
| Other Working Capital | -1,268 | -1,297 | -270 | -8,232 | -8,165 |
| Other Operating Activity | 4,723 | 1,152 | 1,490 | 10,966 | 9,930 |
| Operating Cash Flow | $-33,870 | $-23,818 | $-12,112 | $-55,227 | $-46,051 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 56,072 | 60,426 | 30,242 | -83,965 | 26,500 |
| PPE Investments | -27 | -21 | -14 | -1,224 | -1,104 |
| Purchase Of Investment | -10,000 | -10,000 | N/A | -2,500 | -108,858 |
| Purchase Sale Intangibles | -110 | -110 | N/A | -194 | -251 |
| Other Investing Activity | -110 | -110 | 1 | -194 | -251 |
| Investing Cash Flow | $45,935 | $50,295 | $30,229 | $-87,883 | $-83,714 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 502 | 278 | 67 | 181 | 224 |
| Financing Cash Flow | $502 | $278 | $67 | $181 | $224 |
| Beginning Cash Position | 46,799 | 46,799 | 46,799 | 189,728 | 189,728 |
| End Cash Position | 59,367 | 73,554 | 64,982 | 46,799 | 60,187 |
| Net Cash Flow | $12,568 | $26,755 | $18,184 | $-142,930 | $-129,541 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,870 | -23,818 | -12,112 | -55,227 | -46,051 |
| Capital Expenditure | -27 | -21 | -14 | -1,224 | -1,104 |
| Free Cash Flow | -33,897 | -23,839 | -12,126 | -56,452 | -47,156 |